Davis Polk advised the joint book-running managers, J.P. Morgan Securities LLC and Jefferie, in the offering.Deciphera Pharmaceuticals, Inc. executed a $172.5 million SEC-registered common stock and pre-funded…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
